On March 30, 2023, Ms. Lyn Baranowski notified Rani Therapeutics Holdings, Inc. that she does not intend to stand for re-election at the 2023 annual meeting of stockholders of the Company (Annual Meeting). Accordingly, Ms. Baranowski will cease to be a member of the Board of Directors of the Company and the Compensation Committee and the Nominating and Corporate Governance Committee thereof, effective as of the date of the Annual Meeting. Ms. Baranowski's decision to not stand for re-election is not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.235 USD | -0.29% | -10.38% | +56.02% |
05-16 | UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating | MT |
05-07 | HC Wainwright Adjusts Price Target on Rani Therapeutics Holdings to $13 From $12, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.02% | 138M | |
+7.68% | 115B | |
+12.74% | 107B | |
-13.29% | 22.31B | |
-3.99% | 21.6B | |
-6.39% | 18.23B | |
-39.93% | 17.62B | |
+6.80% | 14.26B | |
+32.71% | 12.37B | |
-28.68% | 8.28B |
- Stock Market
- Equities
- RANI Stock
- News Rani Therapeutics Holdings, Inc.
- Lyn Baranowski, A Member of the Board of Directors of Rani Therapeutics Holdings, Inc. and the Compensation Committee and the Nominating and Corporate Governance Committee, Will Not Stand for Re-Election